TRAJENTAMET 2.5 mg/500 mg linagliptin 2.5 mg / metformin hydrochloride 500 mg film-coated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

trajentamet 2.5 mg/500 mg linagliptin 2.5 mg / metformin hydrochloride 500 mg film-coated tablet bottle

boehringer ingelheim pty ltd - linagliptin, quantity: 2.5 mg; metformin hydrochloride, quantity: 500 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; iron oxide yellow; hypromellose; titanium dioxide; copovidone; arginine; maize starch; purified talc; magnesium stearate; propylene glycol - trajentamet is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate, in patients inadequately controlled on metformin alone, or those already being treated and well controlled with the free combination of linagliptin and metformin. trajentamet is indicated in combination with a sulfonylurea (i.e., triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a sulfonylurea. trajentamet is indicated in combination with an sglt2 inhibitor (i.e. triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled on their maximum tolerated dose of metformin and an sglt2 inhibitor. trajentamet is indicated as add-on to insulin (i.e., triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when insulin and metformin alone do not provide adequate glycaemic control.

TRAJENTAMET 2.5 mg/1000 mg linagliptin 2.5 mg / metformin hydrochloride 1000 mg film-coated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

trajentamet 2.5 mg/1000 mg linagliptin 2.5 mg / metformin hydrochloride 1000 mg film-coated tablet bottle

boehringer ingelheim pty ltd - metformin hydrochloride, quantity: 1000 mg; linagliptin, quantity: 2.5 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; propylene glycol; maize starch; purified talc; hypromellose; iron oxide red; arginine; magnesium stearate; titanium dioxide; copovidone - trajentamet is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate, in patients inadequately controlled on metformin alone, or those already being treated and well controlled with the free combination of linagliptin and metformin. trajentamet is indicated in combination with a sulfonylurea (i.e., triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a sulfonylurea. trajentamet is indicated in combination with an sglt2 inhibitor (i.e. triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled on their maximum tolerated dose of metformin and an sglt2 inhibitor. trajentamet is indicated as add-on to insulin (i.e., triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when insulin and metformin alone do not provide adequate glycaemic control.

TRAJENTAMET 2.5 mg/500 mg linagliptin 2.5 mg / metformin hydrochloride 500 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

trajentamet 2.5 mg/500 mg linagliptin 2.5 mg / metformin hydrochloride 500 mg film-coated tablet blister pack

boehringer ingelheim pty ltd - linagliptin, quantity: 2.5 mg; metformin hydrochloride, quantity: 500 mg - tablet, film coated - excipient ingredients: hypromellose; iron oxide yellow; propylene glycol; copovidone; colloidal anhydrous silica; arginine; maize starch; purified talc; magnesium stearate; titanium dioxide - trajentamet is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate, in patients inadequately controlled on metformin alone, or those already being treated and well controlled with the free combination of linagliptin and metformin.,trajentamet is indicated in combination with a sulfonylurea (i.e., triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a sulfonylurea.,trajentamet is indicated in combination with an sglt2 inhibitor (i.e. triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled on their maximum tolerated dose of metformin and an sglt2 inhibitor.,trajentamet is indicated as add-on to insulin (i.e., triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when insulin and metformin alone do not provide adequate glycaemic control.

PHARMACOR TERIFLUNOMIDE teriflunomide 14 mg film-coated tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor teriflunomide teriflunomide 14 mg film-coated tablets blister pack

pharmacor pty ltd - teriflunomide, quantity: 14 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; sodium starch glycollate type a; hyprolose; colloidal anhydrous silica; lactose monohydrate; maize starch; titanium dioxide; macrogol 8000; hypromellose; purified talc; indigo carmine aluminium lake - teriflunomide tablets are indicated for the treatment of patients with relapsing forms of multiple sclerosis to reduce the frequency of clinical relapses and to delay the progression of physical disability.

TERIFLAGIO teriflunomide 14 mg film-coated tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

teriflagio teriflunomide 14 mg film-coated tablets blister pack

arrotex pharmaceuticals pty ltd - teriflunomide, quantity: 14 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; colloidal anhydrous silica; maize starch; microcrystalline cellulose; hyprolose; sodium starch glycollate type a; titanium dioxide; macrogol 8000; hypromellose; purified talc; indigo carmine aluminium lake - teriflunomide tablets are indicated for the treatment of patients with relapsing forms of multiple sclerosis to reduce the frequency of clinical relapses and to delay the progression of physical disability.

TERIFLUNOMIDE GH teriflunomide 14 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

teriflunomide gh teriflunomide 14 mg film-coated tablet blister pack

generic health pty ltd - teriflunomide, quantity: 14 mg - tablet, film coated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; maize starch; lactose monohydrate; sodium starch glycollate type a; microcrystalline cellulose; hyprolose; titanium dioxide; macrogol 8000; hypromellose; purified talc; indigo carmine aluminium lake - teriflunomide tablets are indicated for the treatment of patients with relapsing forms of multiple sclerosis to reduce the frequency of clinical relapses and to delay the progression of physical disability.

Ibuprofen Tablet, film coated 600mg Malta - English - Medicines Authority

ibuprofen tablet, film coated 600mg

accord healthcare limited - ibuprofen - film-coated tablet - ibuprofen 600 mg - antiinflammatory and antirheumatic products

Ibuprofen Tablet, film coated 200mg Malta - English - Medicines Authority

ibuprofen tablet, film coated 200mg

accord healthcare limited - ibuprofen - film-coated tablet - ibuprofen 200 mg - antiinflammatory and antirheumatic products

Ibuprofen Tablet, film coated 400mg Malta - English - Medicines Authority

ibuprofen tablet, film coated 400mg

accord healthcare limited - ibuprofen - film-coated tablet - ibuprofen 400 mg - antiinflammatory and antirheumatic products

APO-IBUPROFEN 400 ibuprofen 400 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-ibuprofen 400 ibuprofen 400 mg film-coated tablet blister pack

arrotex pharmaceuticals pty ltd - ibuprofen, quantity: 400 mg - tablet, film coated - excipient ingredients: sodium lauryl sulfate; microcrystalline cellulose; lactose monohydrate; purified water; macrogol 6000; croscarmellose sodium; purified talc; colloidal anhydrous silica; titanium dioxide; hypromellose; stearic acid; povidone - for the temporary relief of pain and/or inflammation associated with headache, migraine headache, tension headache, sinus pain, toothache, dental,procedures, backache, muscular aches and pains, period pain, sore throat, tennis elbow, arthritis, rheumatic pain and aches and pains associated with,colds and flu. reduces fever.